Board & ownership
- Board
- 1 member
Go to Board & ownership
LIVALO Pharma
Active Risk: not assessedSummary
LIVALO Pharma is younger than twelve months; there is no public track record yet to compute a bankruptcy probability from. The company has been active since 2026 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Overview
Activity
Other business support services
NACE 82990
1 site
Size
No accounts; a small general or limited partnership need not file
Financial health
No score: no figuresToo young for a probability
Structure
- Board
- 1 member
Signals- Young companyShow the evidence
Signals
1 signal.
+raises risk
raises risk · Young company
Founded in 2026, under 3 years in business. Failure risk is statistically highest between 2 and 8 years after founding.
KBO · incorporation dateAge against the risk zone
Checked, nothing found (1)
- IncorporationAppointment: Godelieve Van Look (non-statutory…
Key points
By topic
Timeline
- Events
- 1
- Since
- 2026
Company details
- Sites
- 1
- Legal form
- Limited partnership
- Activity
- Other business support servicesNACE 82990
- Founded
- 20-04-2026
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 14
- Financial year
- From 1 July to 30 June
- Annual meeting
- Third Thursday of December at 18:00
- Purpose
- Alle activiteiten met betrekking tot de farmaceutische sector, met inbegrip van maar niet…
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check Who is behind this young company, and which other companies do they have?Network investigator Is the registered address a letterbox address or a business centre?Addresses
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.